Funding · Company
Bonum Therapeutics, Inc.
Seattle, WABiotech & Pharma
Bonum Therapeutics, Inc. of Seattle, WA has disclosed $72M across 2 Form D offerings filed with the SEC between Nov 29, 2022 and Apr 17, 2026.
$72M
Total disclosed
2
Form D offerings
2021
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$27M
Form D · Apr 17, 2026 ↗
Q2 2026
· target $32M
$45M
Form D · Nov 29, 2022 ↗
Q4 2022
· target $93M
Filing details
HeadquartersSeattle, WAIndustryBiotech & Pharma (Biotechnology)Incorporated2021SEC CIK0001898714Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →